23 research outputs found

    Orbit optimization for ASTROD-GW and its time delay interferometry with two arms using CGC ephemeris

    Full text link
    ASTROD-GW (ASTROD [Astrodynamical Space Test of Relativity using Optical Devices] optimized for Gravitation Wave detection) is an optimization of ASTROD to focus on the goal of detection of gravitation waves. The detection sensitivity is shifted 52 times toward larger wavelength compared to that of LISA. The mission orbits of the 3 spacecraft forming a nearly equilateral triangular array are chosen to be near the Sun-Earth Lagrange points L3, L4 and L5. The 3 spacecraft range interferometrically with one another with arm length about 260 million kilometers. In order to attain the requisite sensitivity for ASTROD-GW, laser frequency noise must be suppressed below the secondary noises such as the optical path noise, acceleration noise etc. For suppressing laser frequency noise, we need to use time delay interferometry (TDI) to match the two different optical paths (times of travel). Since planets and other solar-system bodies perturb the orbits of ASTROD-GW spacecraft and affect the (TDI), we simulate the time delay numerically using CGC 2.7 ephemeris framework. To conform to the ASTROD-GW planning, we work out a set of 20-year optimized mission orbits of ASTROD-GW spacecraft starting at June 21, 2028, and calculate the residual optical path differences in the first and second generation TDI for one-detector case. In our optimized mission orbits for 20 years, changes of arm length are less than 0.0003 AU; the relative Doppler velocities are less than 3m/s. All the second generation TDI for one-detector case satisfies the ASTROD-GW requirement.Comment: 17 pages, 7 figures, 1 tabl

    Numerical simulation of time delay interferometry for eLISA/NGO

    Full text link
    eLISA/NGO is a new gravitational wave detection proposal with arm length of 10^6 km and one interferometer down-scaled from LISA. Just like LISA and ASTROD-GW, in order to attain the requisite sensitivity for eLISA/NGO, laser frequency noise must be suppressed to below the secondary noises such as the optical path noise, acceleration noise etc. In previous papers, we have performed the numerical simulation of the time delay interferometry (TDI) for LISA and ASTROD-GW with one arm dysfunctional by using the CGC 2.7 ephemeris. The results are well below their respective limits which the laser frequency noise is required to be suppressed. In this paper, we follow the same procedure to simulate the time delay interferometry numerically. To do this, we work out a set of 1000-day optimized mission orbits of the eLISA/NGO spacecraft starting at January 1st, 2021 using the CGC 2.7 ephemeris framework. We then use the numerical method to calculate the residual optical path differences in the second-generation TDI solutions as in our previous papers. The maximum path length difference, for all configurations calculated, is below 13 mm (43 ps). It is well below the limit which the laser frequency noise is required to be suppressed for eLISA/NGO. We compare and discuss the resulting differences due to the different arm lengths for various mission proposals -- eLISA/NGO, an NGO-LISA-type mission with a nominal arm length of 2 x 10^6 km, LISA and ASTROD-GW.Comment: 17 pages, 13 figures, 3 tables, minor changes in description to match the accepted version of Classical and Quantum Gravity. arXiv admin note: text overlap with arXiv:1102.496

    Orbital effects of a monochromatic plane gravitational wave with ultra-low frequency incident on a gravitationally bound two-body system

    Full text link
    We analytically compute the long-term orbital variations of a test particle orbiting a central body acted upon by an incident monochromatic plane gravitational wave. We assume that the characteristic size of the perturbed two-body system is much smaller than the wavelength of the wave. Moreover, we also suppose that the wave's frequency is much smaller than the particle's orbital one. We make neither a priori assumptions about the direction of the wavevector nor on the orbital geometry of the planet. We find that, while the semi-major axis is left unaffected, the eccentricity, the inclination, the longitude of the ascending node, the longitude of pericenter and the mean anomaly undergo non-vanishing long-term changes. They are not secular trends because of the slow modulation introduced by the tidal matrix coefficients and by the orbital elements themselves. They could be useful to indepenedently constrain the ultra-low frequency waves which may have been indirectly detected in the BICEP2 experiment. Our calculation holds, in general, for any gravitationally bound two-body system whose characteristic frequency is much larger than the frequency of the external wave. It is also valid for a generic perturbation of tidal type with constant coefficients over timescales of the order of the orbital period of the perturbed particle.Comment: LaTex2e, 24 pages, no figures, no tables. Changes suggested by the referees include

    Synthetic Nanoparticles for Vaccines and Immunotherapy

    Get PDF
    The immune system plays a critical role in our health. No other component of human physiology plays a decisive role in as diverse an array of maladies, from deadly diseases with which we are all familiar to equally terrible esoteric conditions: HIV, malaria, pneumococcal and influenza infections; cancer; atherosclerosis; autoimmune diseases such as lupus, diabetes, and multiple sclerosis. The importance of understanding the function of the immune system and learning how to modulate immunity to protect against or treat disease thus cannot be overstated. Fortunately, we are entering an exciting era where the science of immunology is defining pathways for the rational manipulation of the immune system at the cellular and molecular level, and this understanding is leading to dramatic advances in the clinic that are transforming the future of medicine.1,2 These initial advances are being made primarily through biologic drugs– recombinant proteins (especially antibodies) or patient-derived cell therapies– but exciting data from preclinical studies suggest that a marriage of approaches based in biotechnology with the materials science and chemistry of nanomaterials, especially nanoparticles, could enable more effective and safer immune engineering strategies. This review will examine these nanoparticle-based strategies to immune modulation in detail, and discuss the promise and outstanding challenges facing the field of immune engineering from a chemical biology/materials engineering perspectiveNational Institutes of Health (U.S.) (Grants AI111860, CA174795, CA172164, AI091693, and AI095109)United States. Department of Defense (W911NF-13-D-0001 and Awards W911NF-07-D-0004

    Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples

    No full text
    Funder: NCI U24CA211006Abstract: The Cancer Genome Atlas (TCGA) and International Cancer Genome Consortium (ICGC) curated consensus somatic mutation calls using whole exome sequencing (WES) and whole genome sequencing (WGS), respectively. Here, as part of the ICGC/TCGA Pan-Cancer Analysis of Whole Genomes (PCAWG) Consortium, which aggregated whole genome sequencing data from 2,658 cancers across 38 tumour types, we compare WES and WGS side-by-side from 746 TCGA samples, finding that ~80% of mutations overlap in covered exonic regions. We estimate that low variant allele fraction (VAF < 15%) and clonal heterogeneity contribute up to 68% of private WGS mutations and 71% of private WES mutations. We observe that ~30% of private WGS mutations trace to mutations identified by a single variant caller in WES consensus efforts. WGS captures both ~50% more variation in exonic regions and un-observed mutations in loci with variable GC-content. Together, our analysis highlights technological divergences between two reproducible somatic variant detection efforts

    ORAL CAPTOPRIL VERSUS PLACEBO AMONG 13634 PATIENTS WITH SUSPECTED ACUTE MYOCARDIAL-INFARCTION - INTERIM-REPORT FROM THE CHINESE CARDIAC STUDY (CCS-1)

    No full text

    ORAL CAPTOPRIL VERSUS PLACEBO AMONG 13634 PATIENTS WITH SUSPECTED ACUTE MYOCARDIAL-INFARCTION - INTERIM-REPORT FROM THE CHINESE CARDIAC STUDY (CCS-1)

    No full text
    corecore